Peptidus – Peptidus

WE DEVELOP BIOINSPIRED
SOLUTIONS

WHAT WE DO?

WHY WE DO IT?

OUR INSPIRATION?

We use Generative Artificial Intelligence (AI) and Structural Biology to Accelerate the Discovery and Optimization of Bioactive Peptides.

The ENGINE behind our PEPTIDES

We utilize a state-of-the-art A.I. technology platform to streamline the design and development of novel bioactive peptide candidates, thereby significantly enhancing their efficacy and viability in in vitro tests

Platform

PUBLIC DATA SCREENING FOR NATURAL PEPTIDES & ADVANCE BIOLOGICAL INPUTS

A.I. BASED MOLECULAR DESIGN

LAB TESTING

KEY MOLECULES

76% success rate in vitro tests

Our Pipeline

Candidate Name Indication R&D Licensing

Candidate Name MastPep

Indication Bovine Mastitis

R&D TLR6

Licensing under-licensing

Bovine mastitis, primarily caused by bacteria such as Staphylococcus aureus, poses significant challenges for dairy farmers. Conventional antibiotic treatments, while common, can lead to antibiotic resistance and disrupt milk production due to quarantine measures. In response, MastPep, a peptide-based anti-infective developed by Peptidus, offers a sustainable solution. MastPep effectively combats mastitis without leaving residues in milk or the environment, eliminating the need for quarantine and reducing milk disposal for producers. This innovation stands as a promising step towards responsible and efficient dairy production.

Global dairy market size: ~ $ 893 billions

Mastitis may affect ~ 70% of the herd & treatment cost may reach ~$ 444/cow

Treatment and milk wastage: $2 billion/year

Candidate Name PepC1

Indication Tissue regeneration

R&D TLR4

Licensing under-licensing

Our PepR5 technology tackles two critical biological pathways: eradicating pathogenic bacteria at the infection site and promoting tissue healing, preventing bacterial infection recurrence. It also modulates the immune system and recruits cells to the infection site for healing. Importantly, this technology is distinguished by its dual-action therapy, treating both infection and promoting healing simultaneously. Being a peptidic molecule, it leaves no undesirable residues for patients or the environment. Additionally, our molecule's unique structural framework, the coil/N-cap/Helix, grants it superior stability under various conditions.